PORTFOLIO Las Vegas 2024 Pharma & Biotech

13–15 Nov 2024 | Las Vegas, United States

Thursday, 14 November 2024 | 09:30 - 10:00

CASE STUDY: Regular plant value assessment-maximizing utility through effective repurposing

Format:In-person
Location:Pavilion 6
Track:
CAPEX
  • NEW VS. REPURPOSED MANUFACTURING FACILITIES: EXPANSIONS ON AMERICAN MARKET
124 participants

Exploring comprehensive strategies to harness the untapped potential of existing facilities within the ever-evolving pharmaceutical portfolio landscape. 

  • Evaluating the current state of assets against changing market dynamics and portfolio priorities. 

  • Implementing decision-making frameworks tailored to facility repurposing within broader portfolio considerations. 

  • Conducting thorough risk assessments to anticipate challenges in facility transformations. 

  • Maximized ROI and future readiness.